169 related articles for article (PubMed ID: 38539243)
1. A systematic review of progranulin concentrations in biofluids in over 7,000 people-assessing the pathogenicity of GRN mutations and other influencing factors.
Swift IJ; Rademakers R; Finch N; Baker M; Ghidoni R; Benussi L; Binetti G; Rossi G; Synofzik M; Wilke C; Mengel D; Graff C; Takada LT; Sánchez-Valle R; Antonell A; Galimberti D; Fenoglio C; Serpente M; Arcaro M; Schreiber S; Vielhaber S; Arndt P; Santana I; Almeida MR; Moreno F; Barandiaran M; Gabilondo A; Stubert J; Gómez-Tortosa E; Agüero P; Sainz MJ; Gohda T; Murakoshi M; Kamei N; Kittel-Schneider S; Reif A; Weigl J; Jian J; Liu C; Serrero G; Greither T; Theil G; Lohmann E; Gazzina S; Bagnoli S; Coppola G; Bruni A; Quante M; Kiess W; Hiemisch A; Jurkutat A; Block MS; Carlson AM; Bråthen G; Sando SB; Grøntvedt GR; Lauridsen C; Heslegrave A; Heller C; Abel E; Gómez-Núñez A; Puey R; Arighi A; Rotondo E; Jiskoot LC; Meeter LHH; Durães J; Lima M; Tábuas-Pereira M; Lemos J; Boeve B; Petersen RC; Dickson DW; Graff-Radford NR; LeBer I; Sellami L; Lamari F; Clot F; Borroni B; Cantoni V; Rivolta J; Lleó A; Fortea J; Alcolea D; Illán-Gala I; Andres-Cerezo L; Van Damme P; Clarimon J; Steinacker P; Feneberg E; Otto M; van der Ende EL; van Swieten JC; Seelaar H; Zetterberg H; Sogorb-Esteve A; Rohrer JD
Alzheimers Res Ther; 2024 Mar; 16(1):66. PubMed ID: 38539243
[TBL] [Abstract][Full Text] [Related]
2. A Novel Splice-Acceptor Site Mutation in GRN (c.709-2 A>T) Causes Frontotemporal Dementia Spectrum in a Large Family from Southern Italy.
Sassi C; Capozzo R; Gibbs R; Crews C; Zecca C; Arcuti S; Copetti M; Barulli MR; Brescia V; Singleton AB; Logroscino G
J Alzheimers Dis; 2016 May; 53(2):475-85. PubMed ID: 27258413
[TBL] [Abstract][Full Text] [Related]
3. Network analysis of the progranulin-deficient mouse brain proteome reveals pathogenic mechanisms shared in human frontotemporal dementia caused by GRN mutations.
Huang M; Modeste E; Dammer E; Merino P; Taylor G; Duong DM; Deng Q; Holler CJ; Gearing M; Dickson D; Seyfried NT; Kukar T
Acta Neuropathol Commun; 2020 Oct; 8(1):163. PubMed ID: 33028409
[TBL] [Abstract][Full Text] [Related]
4. Partial Tmem106b reduction does not correct abnormalities due to progranulin haploinsufficiency.
Arrant AE; Nicholson AM; Zhou X; Rademakers R; Roberson ED
Mol Neurodegener; 2018 Jun; 13(1):32. PubMed ID: 29929528
[TBL] [Abstract][Full Text] [Related]
5. Intracellular Proteolysis of Progranulin Generates Stable, Lysosomal Granulins that Are Haploinsufficient in Patients with Frontotemporal Dementia Caused by
Holler CJ; Taylor G; Deng Q; Kukar T
eNeuro; 2017; 4(4):. PubMed ID: 28828399
[TBL] [Abstract][Full Text] [Related]
6. Progranulin deficiency induces overactivation of WNT5A expression via TNF-α/NF-κB pathway in peripheral cells from frontotemporal dementia-linked granulin mutation carriers.
Alquézar C; de la Encarnación A; Moreno F; López de Munain A; Martín-Requero Á
J Psychiatry Neurosci; 2016 Jun; 41(4):225-39. PubMed ID: 26624524
[TBL] [Abstract][Full Text] [Related]
7. Analytical and clinical validation of a blood progranulin ELISA in frontotemporal dementias.
Meda F; Simrén J; Borroni B; Cantoni V; Archetti S; Biasiotto G; Andreasson U; Blennow K; Kvartsberg H; Zetterberg H
Clin Chem Lab Med; 2023 Nov; 61(12):2195-2204. PubMed ID: 37476993
[TBL] [Abstract][Full Text] [Related]
8. TMEM106B p.T185S regulates TMEM106B protein levels: implications for frontotemporal dementia.
Nicholson AM; Finch NA; Wojtas A; Baker MC; Perkerson RB; Castanedes-Casey M; Rousseau L; Benussi L; Binetti G; Ghidoni R; Hsiung GY; Mackenzie IR; Finger E; Boeve BF; Ertekin-Taner N; Graff-Radford NR; Dickson DW; Rademakers R
J Neurochem; 2013 Sep; 126(6):781-91. PubMed ID: 23742080
[TBL] [Abstract][Full Text] [Related]
9. Progranulin plasma levels predict the presence of GRN mutations in asymptomatic subjects and do not correlate with brain atrophy: results from the GENFI study.
Galimberti D; Fumagalli GG; Fenoglio C; Cioffi SMG; Arighi A; Serpente M; Borroni B; Padovani A; Tagliavini F; Masellis M; Tartaglia MC; van Swieten J; Meeter L; Graff C; de Mendonça A; Bocchetta M; Rohrer JD; Scarpini E;
Neurobiol Aging; 2018 Feb; 62():245.e9-245.e12. PubMed ID: 29146050
[TBL] [Abstract][Full Text] [Related]
10. White matter hyperintensities in progranulin-associated frontotemporal dementia: A longitudinal GENFI study.
Sudre CH; Bocchetta M; Heller C; Convery R; Neason M; Moore KM; Cash DM; Thomas DL; Woollacott IOC; Foiani M; Heslegrave A; Shafei R; Greaves C; van Swieten J; Moreno F; Sanchez-Valle R; Borroni B; Laforce R; Masellis M; Tartaglia MC; Graff C; Galimberti D; Rowe JB; Finger E; Synofzik M; Vandenberghe R; de Mendonça A; Tagliavini F; Santana I; Ducharme S; Butler C; Gerhard A; Levin J; Danek A; Frisoni GB; Sorbi S; Otto M; Zetterberg H; Ourselin S; Cardoso MJ; Rohrer JD;
Neuroimage Clin; 2019; 24():102077. PubMed ID: 31835286
[TBL] [Abstract][Full Text] [Related]
11. Individuals with progranulin haploinsufficiency exhibit features of neuronal ceroid lipofuscinosis.
Ward ME; Chen R; Huang HY; Ludwig C; Telpoukhovskaia M; Taubes A; Boudin H; Minami SS; Reichert M; Albrecht P; Gelfand JM; Cruz-Herranz A; Cordano C; Alavi MV; Leslie S; Seeley WW; Miller BL; Bigio E; Mesulam MM; Bogyo MS; Mackenzie IR; Staropoli JF; Cotman SL; Huang EJ; Gan L; Green AJ
Sci Transl Med; 2017 Apr; 9(385):. PubMed ID: 28404863
[TBL] [Abstract][Full Text] [Related]
12. Progranulin as a therapeutic target for dementia.
Galimberti D; Fenoglio C; Scarpini E
Expert Opin Ther Targets; 2018 Jul; 22(7):579-585. PubMed ID: 29889573
[TBL] [Abstract][Full Text] [Related]
13. Peripheral GRN mRNA and Serum Progranulin Levels as a Potential Indicator for Both the Presence of Splice Site Mutations and Individuals at Risk for Frontotemporal Dementia.
Guven G; Bilgic B; Tufekcioglu Z; Erginel Unaltuna N; Hanagasi H; Gurvit H; Singleton A; Hardy J; Emre M; Gulec C; Bras J; Guerreiro R; Lohmann E
J Alzheimers Dis; 2019; 67(1):159-167. PubMed ID: 30475763
[TBL] [Abstract][Full Text] [Related]
14. rs5848 polymorphism and serum progranulin level.
Hsiung GY; Fok A; Feldman HH; Rademakers R; Mackenzie IR
J Neurol Sci; 2011 Jan; 300(1-2):28-32. PubMed ID: 21047645
[TBL] [Abstract][Full Text] [Related]
15. Longitudinal structural gray matter and white matter MRI changes in presymptomatic progranulin mutation carriers.
Olm CA; McMillan CT; Irwin DJ; Van Deerlin VM; Cook PA; Gee JC; Grossman M
Neuroimage Clin; 2018; 19():497-506. PubMed ID: 29984158
[TBL] [Abstract][Full Text] [Related]
16. Latozinemab, a novel progranulin-elevating therapy for frontotemporal dementia.
Kurnellas M; Mitra A; Schwabe T; Paul R; Arrant AE; Roberson ED; Ward M; Yeh F; Long H; Rosenthal A
J Transl Med; 2023 Jun; 21(1):387. PubMed ID: 37322482
[TBL] [Abstract][Full Text] [Related]
17. TMEM106B regulates progranulin levels and the penetrance of FTLD in GRN mutation carriers.
Finch N; Carrasquillo MM; Baker M; Rutherford NJ; Coppola G; Dejesus-Hernandez M; Crook R; Hunter T; Ghidoni R; Benussi L; Crook J; Finger E; Hantanpaa KJ; Karydas AM; Sengdy P; Gonzalez J; Seeley WW; Johnson N; Beach TG; Mesulam M; Forloni G; Kertesz A; Knopman DS; Uitti R; White CL; Caselli R; Lippa C; Bigio EH; Wszolek ZK; Binetti G; Mackenzie IR; Miller BL; Boeve BF; Younkin SG; Dickson DW; Petersen RC; Graff-Radford NR; Geschwind DH; Rademakers R
Neurology; 2011 Feb; 76(5):467-74. PubMed ID: 21178100
[TBL] [Abstract][Full Text] [Related]
18. Progranulin Levels in Plasma and Cerebrospinal Fluid in Granulin Mutation Carriers.
Meeter LH; Patzke H; Loewen G; Dopper EG; Pijnenburg YA; van Minkelen R; van Swieten JC
Dement Geriatr Cogn Dis Extra; 2016; 6(2):330-340. PubMed ID: 27703466
[TBL] [Abstract][Full Text] [Related]
19. Serum progranulin levels in patients with frontotemporal lobar degeneration and Alzheimer's disease: detection of GRN mutations in a Spanish cohort.
Antonell A; Gil S; Sánchez-Valle R; Balasa M; Bosch B; Prat MC; Chiollaz AC; Fernández M; Yagüe J; Molinuevo JL; Lladó A
J Alzheimers Dis; 2012; 31(3):581-91. PubMed ID: 22647257
[TBL] [Abstract][Full Text] [Related]
20. Trehalose upregulates progranulin expression in human and mouse models of GRN haploinsufficiency: a novel therapeutic lead to treat frontotemporal dementia.
Holler CJ; Taylor G; McEachin ZT; Deng Q; Watkins WJ; Hudson K; Easley CA; Hu WT; Hales CM; Rossoll W; Bassell GJ; Kukar T
Mol Neurodegener; 2016 Jun; 11(1):46. PubMed ID: 27341800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
